https://io.nihr.ac.uk/techbriefings/leuprorelin-acetate-in-addition-to-tamoxifen-or-an-aromatase-inhibitor-for-er-positive-early-stage-breast-cancer-in-premenopausal-women-adjuvant/
Leuprorelin acetate in addition to tamoxifen or an aromatase inhibitor for ER-positive early stage...
Nov 8, 2024 - Leuprorelin acetate in addition to tamoxifen or an aromatase inhibitor is in clinical development as an adjuvant treatment of ER-positive early stage breast...
in addition toleuprorelin acetatearomatase inhibitorer positiveearly stage